Dashboard
Manage Tickers

JSPRJasper Therapeutics, Inc.

Nasdaq www.jaspertherapeutics.com


$ 21.61 $ -1.60 (-6.89 %)    

Friday, 19-Apr-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 414.63 $ -8.78 (-2.07 %)
DIA $ 379.83 $ 1.99 (0.53 %)
SPY $ 494.89 $ -4.63 (-0.93 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.67 (0.3 %)
$ 23.21
$ 23.40
$ 21.59 x 200
$ 0.00 x 0
$ 21.55 - $ 23.40
$ 4.00 - $ 31.01
120,088
na
349.63M
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-05-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-08-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-18-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-24-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 03-26-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evercore-isi-group-initiates-coverage-on-jasper-therapeutics-with-outperform-rating-announces-price-target-of-65
Evercore ISI Group Initiates Coverage On J...
04/03/2024 11:34:01

Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rat...

rbc-capital-initiates-coverage-on-jasper-therapeutics-with-outperform-rating-announces-price-target-of-70
RBC Capital Initiates Coverage On Jasper T...
03/28/2024 08:36:23

RBC Capital analyst Gregory Renza initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rating and annou...

jasper-therapeutics-announces-first-patient-dosed-in-phase-1b2a-spotlight-clinical-study-of-briquilimab-in-chronic-inducible-urticaria
Jasper Therapeutics Announces First Patien...
03/19/2024 12:05:22

Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibo...

td-cowen-initiates-coverage-on-jasper-therapeutics-with-outperform-rating
TD Cowen Initiates Coverage On Jasper Ther...
03/18/2024 12:34:14

TD Cowen analyst Yaron Werber initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rating.

jasper-therapeutics-announces-new-data-presented-on-briquilimab-conditioning-in-patients-with-fanconi-anemia
Jasper Therapeutics Announces New Data Pre...
03/15/2024 12:04:44

Three additional patients with Fanconi Anemia treated with briquilimab prior to stem cell transplantAll six patients with Fanco...

oppenheimer-maintains-outperform-on-jasper-therapeutics-maintains-80-price-target
Oppenheimer Maintains Outperform on Jasper...
03/07/2024 13:02:28

Oppenheimer analyst Jay Olson maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and maintains $80 price target.

jasper-therapeutics-won-clearance-for-initiation-of-its-phase-1b2a-beacon-study-of-subcutaneous-briquilimab-in-csu-phase-1b2a-spotlight-study-initiated-a-phase-1-trial-of-briquilimab-as-second-line-therapy-in-subjects-with-myelodysplastic-syndromes
Jasper Therapeutics Won Clearance for Init...
03/04/2024 12:39:22

Highlights for 2023 and Recent Weeks Successfully completed an underwritten offering of 3,900,000 shares of its common stock...

jasper-therapeutics-reported-fy23-eps-loss-of-150-cash-balance-of-869m
Jasper Therapeutics Reported FY23 EPS Loss...
03/04/2024 12:35:36

Fiscal 2023 Financial Results Cash and cash equivalents as of December 31, 2023, totaled $86.9 million.   Research and...

jasper-therapeutics-presents-data-from-preclinical-briquilimab-studies-at-the-american-academy-of-allergy-asthma-and-immunology-annual-meeting
Jasper Therapeutics Presents Data From Pre...
02/23/2024 13:06:42

 Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antib...

over-15m-bet-on-aon-check-out-these-3-stocks-insiders-are-buying
Over $15M Bet On Aon? Check Out These 3 St...
02/12/2024 13:36:25

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

why-fmc-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why FMC Shares Are Trading Lower By Around...
02/06/2024 18:17:47

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fo...

jasper-therapeutics-announces-pricing-of-50m-underwritten-offering-of-39m-shares-of-common-stock-at-a-price-of-1295share
Jasper Therapeutics Announces Pricing Of $...
02/06/2024 14:01:07

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on developing novel ...

jasper-therapeutics-announces-preclinical-data-presentations-at-american-academy-of-allergy-asthma-and-immunology-annual-meeting
Jasper Therapeutics Announces Preclinical ...
02/05/2024 13:11:15

etails of the presentations are as follows:Abstract Title: Briquilimab, An Anti-CD117 Antibody, Prevents Passive Systemic Anaph...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
01/18/2024 17:31:14

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 17:31:12

jasper-therapeutics-announces-recent-accomplishments-and-upcoming-milestones
Jasper Therapeutics Announces Recent Accom...
01/05/2024 13:36:55

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively - Pa...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
01/04/2024 13:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
01/04/2024 00:50:04

jasper-therapeutics-announced-that-it-will-effect-a-1-for-10-reverse-stock-split-of-its-common-stock-effective-1201-am-et-on-thursday-january-4-2024
Jasper Therapeutics Announced That It Will...
01/02/2024 13:02:57

jasper-therapeutics-presented-final-results-from-phase-1-study-of-briquilimab-in-patients-with-aml-or-mds-undergoing-hematopoietic-cell-transplant-in-oral-presentation-at-ash-2023
Jasper Therapeutics Presented Final Result...
12/11/2023 08:11:37

Jasper Therapeutics announced positive final results from the Phase 1 study of briquilimab in combination with fludarabine and ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)